Serina Therapeutics, Inc. (SER) — Revenue
| Fiscal Year | Revenue | Change YoY |
|---|---|---|
| 2025 | $130.0K | +132.1% |
| 2024 | $56.0K | -98.2% |
| 2023 | $3.15M | +9173.5% |
| 2022 | $34.0K | -76.4% |
| 2021 | $144.0K | -60.1% |
| 2020 | $361.0K | -79.1% |
| 2019 | $1.73M | +23.8% |
| 2018 | $1.40M | -0.6% |
| 2017 | $1.40M | — |
| Fiscal Year | Revenue | Change YoY |
|---|---|---|
| 2025 | $130.0K | +132.1% |
| 2024 | $56.0K | -98.2% |
| 2023 | $3.15M | +9173.5% |
| 2022 | $34.0K | -76.4% |
| 2021 | $144.0K | -60.1% |
| 2020 | $361.0K | -79.1% |
| 2019 | $1.73M | +23.8% |
| 2018 | $1.40M | -0.6% |
| 2017 | $1.40M | — |